Switching to Insulin Degludec improves glycemic control in patients with type 2 diabetes (T2dm) in a real-world setting. Results of the EU-TREAT study from six European countries with special emphasis on the Austrian sub-cohort

S Pusarnig; Lars Stechemesser; A Vonbank; R Weitgasser; HR Schonherr; H Sourij; CK Tikkanen; A Brugger; R Prager

Switching to Insulin Degludec improves glycemic control in patients with type 2 diabetes (T2dm) in a real-world setting. Results of the EU-TREAT study from six European countries with special emphasis on the Austrian sub-cohort

S Pusarnig, Lars Stechemesser, A Vonbank, R Weitgasser, HR Schonherr, H Sourij, CK Tikkanen, A Brugger, R Prager

Department of Internal Medicine I- Division of Gastroenterology, Hepatology, Nephrology, Metabolism and Diabetologylog

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	177-177
Journal	WIENER KLINISCHE WOCHENSCHRIFT
Volume	129
Publication status	Published - 2017

Cite this

Pusarnig, S., Stechemesser, L., Vonbank, A., Weitgasser, R., Schonherr, HR., Sourij, H., Tikkanen, CK., Brugger, A., & Prager, R. (2017). Switching to Insulin Degludec improves glycemic control in patients with type 2 diabetes (T2dm) in a real-world setting. Results of the EU-TREAT study from six European countries with special emphasis on the Austrian sub-cohort. WIENER KLINISCHE WOCHENSCHRIFT, 129, 177-177.

@article{9f5b24d01dc944c7bc55f678abfc5972,

title = "Switching to Insulin Degludec improves glycemic control in patients with type 2 diabetes (T2dm) in a real-world setting. Results of the EU-TREAT study from six European countries with special emphasis on the Austrian sub-cohort",

author = "S Pusarnig and Lars Stechemesser and A Vonbank and R Weitgasser and HR Schonherr and H Sourij and CK Tikkanen and A Brugger and R Prager",

year = "2017",

language = "English",

volume = "129",

pages = "177--177",

journal = "WIENER KLINISCHE WOCHENSCHRIFT",

issn = "0043-5325",

publisher = "Springer Nature",

}

Pusarnig, S, Stechemesser, L, Vonbank, A, Weitgasser, R, Schonherr, HR, Sourij, H, Tikkanen, CK, Brugger, A & Prager, R 2017, 'Switching to Insulin Degludec improves glycemic control in patients with type 2 diabetes (T2dm) in a real-world setting. Results of the EU-TREAT study from six European countries with special emphasis on the Austrian sub-cohort', WIENER KLINISCHE WOCHENSCHRIFT, vol. 129, pp. 177-177.

Switching to Insulin Degludec improves glycemic control in patients with type 2 diabetes (T2dm) in a real-world setting. Results of the EU-TREAT study from six European countries with special emphasis on the Austrian sub-cohort. / Pusarnig, S; Stechemesser, Lars; Vonbank, A et al.
In: WIENER KLINISCHE WOCHENSCHRIFT, Vol. 129, 2017, p. 177-177.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Switching to Insulin Degludec improves glycemic control in patients with type 2 diabetes (T2dm) in a real-world setting. Results of the EU-TREAT study from six European countries with special emphasis on the Austrian sub-cohort

AU - Pusarnig, S

AU - Stechemesser, Lars

AU - Vonbank, A

AU - Weitgasser, R

AU - Schonherr, HR

AU - Sourij, H

AU - Tikkanen, CK

AU - Brugger, A

AU - Prager, R

PY - 2017

Y1 - 2017

M3 - Abstract (Journal)

SN - 0043-5325

VL - 129

SP - 177

EP - 177

JO - WIENER KLINISCHE WOCHENSCHRIFT

JF - WIENER KLINISCHE WOCHENSCHRIFT

ER -